August 8, 2016
Unum Therapeutics to Present at 2016 Wedbush PacGrow Healthcare Conference
CAMBRIDGE, MA, August 8, 2016 – Unum Therapeutics, a clinical stage biopharmaceutical company developing a universal cellular immunotherapy to treat multiple cancers, today announced that President and Chief Executive Officer Chuck Wilson will present at the Wedbush PacGrow Healthcare Conference on August 17, 2016 at 1:20 pm ET. The conference is being held August 16-17, 2016 at the Le Parker Meridien in New York.
Unum uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. The Company’s lead program, which combines Unum’s proprietary Antibody-Coupled T-cell Receptor (ACTR) technology with rituximab, is in Phase 1 clinical testing to assess its safety and efficacy. The company is headquartered in Cambridge, MA. For more information, visit www.unumrx.com.
Sam Brown Inc.